Bhavin Shah - Concepedia

Author

Bhavin Shah

The University of Texas MD Anderson Cancer Center

Also Known As

Bhavin Shah

Publications

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Dana-Farber Cancer Institute Huntsman Cancer Institute University of Utah Baylor College of Medicine

About

Bhavin Shah is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	2.9K
2	Cell Biology	2	2	1.3K
3	Immunology	2	2	1.3K
4	Allergy	1	1	1.1K
5	Pharmacology	1	1	189

Bhavin Shah

Publications

Citations

H-Index

Page 1

	Year	Citations
T Helper 17 Lineage Differentiation Is Programmed by Orphan Nuclear Receptors RORα and RORγ Xuexian O. Yang, Bhanu P. Pappu, Roza Nurieva, Immunity Cell LineageDevelopmental BiologyImmune Cell DevelopmentGeneticsGene Regulation	2008	1.6K
Molecular Antagonism and Plasticity of Regulatory and Inflammatory T Cell Programs Xuexian O. Yang, Roza Nurieva, Gustavo Martínez, Immunity InflammationAllergyAutoimmune DiseaseT-regulatory CellImmunology	2008	1.1K
Regulation of inflammatory responses by IL-17F Xuexian O. Yang, Seon Hee Chang, Heon Park, The Journal of Experimental Medicine	2008	734
Highly Active Combination of BRD4 Antagonist and Histone Deacetylase Inhibitor against Human Acute Myelogenous Leukemia Cells Warren Fiskus, Sunil Sharma, Jun Qi, Molecular Cancer Therapeutics Histone ModificationsHistone Deacetylase InhibitorFamily MembersMixed-phenotype Acute LeukemiaImmunology	2014	189
Histone deacetylase inhibitor treatment induces ‘BRCAness’ and synergistic lethality with PARP inhibitor and cisplatin against human triple negative breast cancer cells Kyungsoo Ha, Warren Fiskus, Dong Soon Choi, Oncotarget	2014	150
BET Protein Antagonist JQ1 Is Synergistically Lethal with FLT3 Tyrosine Kinase Inhibitor (TKI) and Overcomes Resistance to FLT3-TKI in AML Cells Expressing FLT-ITD Warren Fiskus, Sunil Sharma, Jun Qi, Molecular Cancer Therapeutics	2014	137
Synergistic activity of BET protein antagonist-based combinations in mantle cell lymphoma cells sensitive or resistant to ibrutinib Baohua Sun, Bhavin Shah, Warren Fiskus, Blood	2015	106

Page 1